Yi Gu
Directeur Technique/Scientifique/R&D chez TRANSCENTA HOLDING LIMITED
Profil
Yi Gu is currently a Member at the American Association for Cancer Research since 2009 and a Senior Vice President & Head-Research at Transcenta Holding Ltd.
since 2019.
Previously, Dr. Gu worked as a Director-Translational Sciences at AstraZeneca PLC from 2006 to 2015 and as a Vice President-Research & Development at Ambrx, Inc. from 2016 to 2018.
Dr. Gu holds a doctorate degree from Rochester Christian University, conferred in 1998, and an undergraduate degree from Fudan University, conferred in 1990.
Postes actifs de Yi Gu
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Directeur Technique/Scientifique/R&D | 01/02/2019 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/2009 |
Anciens postes connus de Yi Gu
| Sociétés | Poste | Fin |
|---|---|---|
| AMBRX INC | Directeur Technique/Scientifique/R&D | 01/12/2018 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/12/2015 |
Formation de Yi Gu
| Fudan University | Undergraduate Degree |
| Rochester Christian University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
